Rahuman S. Malik Sheriff
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rahuman S. Malik Sheriff has a total of 480 co-authors. Here are the top co-authors by number of shared publications:
- Henning Hermjakob
European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1 SD, UK
16 shared publications Henning Hermjakob
European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK
7 shared publications- Matthias König
Faculty of Life Science, Institute for Biology , Humboldt-Universität zu Berlin , Berlin , Germany
7 shared publications - Tung Vu-Ngoc Nguyen
European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK
7 shared publications - Dagmar Waltemath
Medical Informatics Laboratory, University Medicine Greifswald, Greifswald, Germany
5 shared publications - Andreas Dräger
Data Analytics and Bioinformatics, Institute of Computer Science Martin Luther University Halle‐Wittenberg Halle (Saale) Germany
4 shared publications
Latest Publications
- Open Access
- 5 August 2026
- Published by Springer Nature in npj Complexity
EFECT enables reliable and reproducible stochastic simulations across disciplines
- 5 August 2026
- Published by Springer Nature in npj Complexity
Open AccessEFECT enables reliable and reproducible stochastic simulations across disciplines
- Open Access
- 8 July 2026
- Published by Frontiers Media SA in Frontiers in Systems Biology
- Vol. 6, 1829848
BioModels’ model of the year 2024
Computational modelling is a widely used approach for understanding complex biological systems, enabling researchers to formalise mechanisms, analyse dynamic behaviours, and generate predictive insights across multiple biological scales. The BioModels Model of the Year (MOY) 2024 competition was organised to recognise outstanding modelling contributions from the systems biology community, with a particular focus on early-career researchers and models that demonstrate strong scientific impact, technical rigour, and reproducibility. The initiative also promotes best practices in model dissemination by encouraging submissions that follow community standards and adhere to FAIR principles. Here, we describe the MOY2024 selection process and present the four winning models curated in BioModels. The award-winning submissions span diverse areas of biomedical research, including hepatocyte signalling in metabolic liver disease, cardiac electrophysiology for drug safety assessment, multiscale modelling of intestinal epithelial dynamics, and electromechanical modelling of post-infarction cardiomyocytes. Together, these reproducible and reusable systems biology models illustrate how computational frameworks can advance both fundamental biology and translational biomedical research.
- 8 July 2026
- Published by Frontiers Media SA in Frontiers in Systems Biology
- Vol. 6, 1829848
Open AccessBioModels’ model of the year 2024
Computational modelling is a widely used approach for understanding complex biological systems, enabling researchers to formalise mechanisms, analyse dynamic behaviours, and generate predictive insights across multiple biological scales. The BioModels Model of the Year (MOY) 2024 competition was organised to recognise outstanding modelling contributions from the systems biology community, with a particular focus on early-career researchers and models that demonstrate strong scientific impact, technical rigour, and reproducibility. The initiative also promotes best practices in model dissemination by encouraging submissions that follow community standards and adhere to FAIR principles. Here, we describe the MOY2024 selection process and present the four winning models curated in BioModels. The award-winning submissions span diverse areas of biomedical research, including hepatocyte signalling in metabolic liver disease, cardiac electrophysiology for drug safety assessment, multiscale modelling of intestinal epithelial dynamics, and electromechanical modelling of post-infarction cardiomyocytes. Together, these reproducible and reusable systems biology models illustrate how computational frameworks can advance both fundamental biology and translational biomedical research.
- Open Access
- 31 March 2026
- Published by Wiley in CPT: Pharmacometrics & Systems Pharmacology
- Vol. 15 (4) , e70234
The Potential of Digital Twins for Pediatric Rare Diseases
Rare diseases affect over 300 million people globally, with approximately 75% manifesting in childhood. Their diagnosis is often delayed and approved treatments are lacking for most of the conditions. Pediatric rare diseases research is further complicated by ethical constraints and developmental diversity across childhood. Digital Twins, virtual representations of patients built from mechanistic and AI/ML models, offer a promising solution by enabling hypothesis testing, precision diagnostics, personalized therapies, and in silico trials for pediatric rare diseases. This article discusses the potential of DT applications in advancing precision medicine for pediatric rare diseases, alongside associated regulatory perspectives, modeling strategies, uncertainty analysis, as well as data, ethical and legal challenges.
- 31 March 2026
- Published by Wiley in CPT: Pharmacometrics & Systems Pharmacology
- Vol. 15 (4) , e70234
Open AccessThe Potential of Digital Twins for Pediatric Rare Diseases
Rare diseases affect over 300 million people globally, with approximately 75% manifesting in childhood. Their diagnosis is often delayed and approved treatments are lacking for most of the conditions. Pediatric rare diseases research is further complicated by ethical constraints and developmental diversity across childhood. Digital Twins, virtual representations of patients built from mechanistic and AI/ML models, offer a promising solution by enabling hypothesis testing, precision diagnostics, personalized therapies, and in silico trials for pediatric rare diseases. This article discusses the potential of DT applications in advancing precision medicine for pediatric rare diseases, alongside associated regulatory perspectives, modeling strategies, uncertainty analysis, as well as data, ethical and legal challenges.
- Open Access
- 1 September 2025
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 41 (9)
SBMLtoOdin and Menelmacar: interactive visualisation of systems biology models for expert and non-expert audiences
Summary: Computational models in biology can increase our understanding of biological systems, be used to answer research questions, and make predictions. Accessibility and reusability of computational models is limited and often restricted to experts in programming and mathematics. This is due to the need to implement entire models and solvers from the mathematical notation models are normally presented as. Here, we present SBMLtoOdin, an R package that translates differential equation models in SBML format from the BioModels database into executable R code using the R package odin, allowing researchers to easily reuse models. We also present Menelmacar, a web-based application that provides interactive visualisations of these models by solving their differential equations in the browser. This platform allows non-experts to simulate and investigate models using an easy-to-use interface. Availability and Implementation: SBMLtoOdin is published under the open source Apache 2.0 licence at https://github.com/bacpop/SBMLtoOdin and can be installed as an R package. The code for the Menelmacar website is published under the MIT License at https://github.com/bacpop/odinviewer, and the website can be found at https://biomodels.bacpop.org/.
- 1 September 2025
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 41 (9)
Open AccessSBMLtoOdin and Menelmacar: interactive visualisation of systems biology models for expert and non-expert audiences
Summary: Computational models in biology can increase our understanding of biological systems, be used to answer research questions, and make predictions. Accessibility and reusability of computational models is limited and often restricted to experts in programming and mathematics. This is due to the need to implement entire models and solvers from the mathematical notation models are normally presented as. Here, we present SBMLtoOdin, an R package that translates differential equation models in SBML format from the BioModels database into executable R code using the R package odin, allowing researchers to easily reuse models. We also present Menelmacar, a web-based application that provides interactive visualisations of these models by solving their differential equations in the browser. This platform allows non-experts to simulate and investigate models using an easy-to-use interface. Availability and Implementation: SBMLtoOdin is published under the open source Apache 2.0 licence at https://github.com/bacpop/SBMLtoOdin and can be installed as an R package. The code for the Menelmacar website is published under the MIT License at https://github.com/bacpop/odinviewer, and the website can be found at https://biomodels.bacpop.org/.
- Open Access
FAIRification of computational models in biology
Computational models are essential for studying complex systems which, particularly in clinical settings, need to be quality-approved and transparent. To enhance the communication of a model’s features and capabilities, we propose an adaptation of the Findability, Accessibility, Interoperability and Reusability (FAIR) indicators published by the Research Data Alliance to assess models encoded in domain-specific standards, such as those established by COMBINE. The assessments guide FAIRification and add value to models.
Open AccessFAIRification of computational models in biology
Computational models are essential for studying complex systems which, particularly in clinical settings, need to be quality-approved and transparent. To enhance the communication of a model’s features and capabilities, we propose an adaptation of the Findability, Accessibility, Interoperability and Reusability (FAIR) indicators published by the Research Data Alliance to assess models encoded in domain-specific standards, such as those established by COMBINE. The assessments guide FAIRification and add value to models.
- Open Access
- 30 November 2024
- Published by Springer Nature in npj Systems Biology and Applications
- Vol. 10 (1) , 1-14
Immune digital twins for complex human pathologies: applications, limitations, and challenges
Digital twins represent a key technology for precision health. Medical digital twins consist of computational models that represent the health state of individual patients over time, enabling optimal therapeutics and forecasting patient prognosis. Many health conditions involve the immune system, so it is crucial to include its key features when designing medical digital twins. The immune response is complex and varies across diseases and patients, and its modelling requires the collective expertise of the clinical, immunology, and computational modelling communities. This review outlines the initial progress on immune digital twins and the various initiatives to facilitate communication between interdisciplinary communities. We also outline the crucial aspects of an immune digital twin design and the prerequisites for its implementation in the clinic. We propose some initial use cases that could serve as “proof of concept” regarding the utility of immune digital technology, focusing on diseases with a very different immune response across spatial and temporal scales (minutes, days, months, years). Lastly, we discuss the use of digital twins in drug discovery and point out emerging challenges that the scientific community needs to collectively overcome to make immune digital twins a reality.
- 30 November 2024
- Published by Springer Nature in npj Systems Biology and Applications
- Vol. 10 (1) , 1-14
Open AccessImmune digital twins for complex human pathologies: applications, limitations, and challenges
Digital twins represent a key technology for precision health. Medical digital twins consist of computational models that represent the health state of individual patients over time, enabling optimal therapeutics and forecasting patient prognosis. Many health conditions involve the immune system, so it is crucial to include its key features when designing medical digital twins. The immune response is complex and varies across diseases and patients, and its modelling requires the collective expertise of the clinical, immunology, and computational modelling communities. This review outlines the initial progress on immune digital twins and the various initiatives to facilitate communication between interdisciplinary communities. We also outline the crucial aspects of an immune digital twin design and the prerequisites for its implementation in the clinic. We propose some initial use cases that could serve as “proof of concept” regarding the utility of immune digital technology, focusing on diseases with a very different immune response across spatial and temporal scales (minutes, days, months, years). Lastly, we discuss the use of digital twins in drug discovery and point out emerging challenges that the scientific community needs to collectively overcome to make immune digital twins a reality.
- Open Access
FROG Analysis Ensures the Reproducibility of Genome Scale Metabolic Models
Genome-scale metabolic models (GEMs) and other constraint-based models (CBMs) play a pivotal role in understanding biological phenotypes and advancing research in areas like metabolic engineering, human disease modelling, drug discovery, and personalized medicine. Despite their growing application, a significant challenge remains in ensuring the reproducibility of GEMs, primarily due to inconsistent reporting and inadequate model documentation of model results. Addressing this gap, we introduce FROG analysis, a community-driven initiative aimed at standardizing reproducibility assessments of CBMs and GEMs. The FROG framework encompasses four key analyses—Flux variability, Reaction deletion, Objective function, and Gene deletion—to produce standardized, numerically reproducible FROG reports. These reports serve as reference datasets, enabling model evaluators, curators, and independent researchers to verify the reproducibility of GEMs systematically. BioModels, a leading repository of systems biology models, has integrated FROG analysis into its curation workflow, enhancing the reproducibility and reusability of submitted GEMs. In our study evaluating 65 GEM submissions from the community, approximately 40% reproduced without intervention, 28% requiring minor adjustments, and 32% needing input from authors. The standardization introduced by FROG analysis facilitated the detection and resolution of issues, ultimately leading to the successful reproduction of all models. By establishing a standardized and comprehensive approach to evaluating GEM reproducibility, FROG analysis significantly contributes to making CBMs and GEMs more transparent, reusable, and reliable for the broader scientific community.
Open AccessFROG Analysis Ensures the Reproducibility of Genome Scale Metabolic Models
Genome-scale metabolic models (GEMs) and other constraint-based models (CBMs) play a pivotal role in understanding biological phenotypes and advancing research in areas like metabolic engineering, human disease modelling, drug discovery, and personalized medicine. Despite their growing application, a significant challenge remains in ensuring the reproducibility of GEMs, primarily due to inconsistent reporting and inadequate model documentation of model results. Addressing this gap, we introduce FROG analysis, a community-driven initiative aimed at standardizing reproducibility assessments of CBMs and GEMs. The FROG framework encompasses four key analyses—Flux variability, Reaction deletion, Objective function, and Gene deletion—to produce standardized, numerically reproducible FROG reports. These reports serve as reference datasets, enabling model evaluators, curators, and independent researchers to verify the reproducibility of GEMs systematically. BioModels, a leading repository of systems biology models, has integrated FROG analysis into its curation workflow, enhancing the reproducibility and reusability of submitted GEMs. In our study evaluating 65 GEM submissions from the community, approximately 40% reproduced without intervention, 28% requiring minor adjustments, and 32% needing input from authors. The standardization introduced by FROG analysis facilitated the detection and resolution of issues, ultimately leading to the successful reproduction of all models. By establishing a standardized and comprehensive approach to evaluating GEM reproducibility, FROG analysis significantly contributes to making CBMs and GEMs more transparent, reusable, and reliable for the broader scientific community.
- Open Access
- 30 July 2024
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 40 (8)
Poincaré and SimBio: a versatile and extensible Python ecosystem for modeling systems
Motivation: Chemical reaction networks (CRNs) play a pivotal role in diverse fields such as systems biology, biochemistry, chemical engineering, and epidemiology. High-level definitions of CRNs enables to use various simulation approaches, including deterministic and stochastic methods, from the same model. However, existing Python tools for simulation of CRN typically wrap external C/C++ libraries for model definition, translation into equations and/or numerically solving them, limiting their extensibility and integration with the broader Python ecosystem. Results: In response, we developed Poincaré and SimBio, two novel Python packages for simulation of dynamical systems and CRNs. Poincaré serves as a foundation for dynamical systems modeling, while SimBio extends this functionality to CRNs, including support for the Systems Biology Markup Language (SBML). Poincaré and SimBio are developed as pure Python packages enabling users to easily extend their simulation capabilities by writing new or leveraging other Python packages. Moreover, this does not compromise the performance, as code can be just-in-time compiled with Numba. Our benchmark tests using curated models from the BioModels repository demonstrate that these tools may provide a potentially superior performance advantage compared to other existing tools. In addition, to ensure a user-friendly experience, our packages use standard typed modern Python syntax that provides a seamless integration with integrated development environments. Our Python-centric approach significantly enhances code analysis, error detection, and refactoring capabilities, positioning Poincaré and SimBio as valuable tools for the modeling community. Availability and implementation: Poincaré and SimBio are released under the MIT license. Their source code is available on GitHub (https://github.com/maurosilber/poincare and https://github.com/hgrecco/simbio) and can be installed from PyPI or conda-forge.
- 30 July 2024
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 40 (8)
Open AccessPoincaré and SimBio: a versatile and extensible Python ecosystem for modeling systems
Motivation: Chemical reaction networks (CRNs) play a pivotal role in diverse fields such as systems biology, biochemistry, chemical engineering, and epidemiology. High-level definitions of CRNs enables to use various simulation approaches, including deterministic and stochastic methods, from the same model. However, existing Python tools for simulation of CRN typically wrap external C/C++ libraries for model definition, translation into equations and/or numerically solving them, limiting their extensibility and integration with the broader Python ecosystem. Results: In response, we developed Poincaré and SimBio, two novel Python packages for simulation of dynamical systems and CRNs. Poincaré serves as a foundation for dynamical systems modeling, while SimBio extends this functionality to CRNs, including support for the Systems Biology Markup Language (SBML). Poincaré and SimBio are developed as pure Python packages enabling users to easily extend their simulation capabilities by writing new or leveraging other Python packages. Moreover, this does not compromise the performance, as code can be just-in-time compiled with Numba. Our benchmark tests using curated models from the BioModels repository demonstrate that these tools may provide a potentially superior performance advantage compared to other existing tools. In addition, to ensure a user-friendly experience, our packages use standard typed modern Python syntax that provides a seamless integration with integrated development environments. Our Python-centric approach significantly enhances code analysis, error detection, and refactoring capabilities, positioning Poincaré and SimBio as valuable tools for the modeling community. Availability and implementation: Poincaré and SimBio are released under the MIT license. Their source code is available on GitHub (https://github.com/maurosilber/poincare and https://github.com/hgrecco/simbio) and can be installed from PyPI or conda-forge.
- Open Access
- 31 May 2024
- Published by F1000 Research Ltd in F1000Research
- Vol. 11, 1265
Systems Biology in ELIXIR: modelling in the spotlight
In this white paper, we describe the founding of a new ELIXIR Community - the Systems Biology Community - and its proposed future contributions to both ELIXIR and the broader community of systems biologists in Europe and worldwide. The Community believes that the infrastructure aspects of systems biology - databases, (modelling) tools and standards development, as well as training and access to cloud infrastructure - are not only appropriate components of the ELIXIR infrastructure, but will prove key components of ELIXIR’s future support of advanced biological applications and personalised medicine. By way of a series of meetings, the Community identified seven key areas for its future activities, reflecting both future needs and previous and current activities within ELIXIR Platforms and Communities. These are: overcoming barriers to the wider uptake of systems biology; linking new and existing data to systems biology models; interoperability of systems biology resources; further development and embedding of systems medicine; provisioning of modelling as a service; building and coordinating capacity building and training resources; and supporting industrial embedding of systems biology. A set of objectives for the Community has been identified under four main headline areas: Standardisation and Interoperability, Technology, Capacity Building and Training, and Industrial Embedding. These are grouped into short-term (3-year), mid-term (6-year) and long-term (10-year) objectives.
- 31 May 2024
- Published by F1000 Research Ltd in F1000Research
- Vol. 11, 1265
Open AccessSystems Biology in ELIXIR: modelling in the spotlight
In this white paper, we describe the founding of a new ELIXIR Community - the Systems Biology Community - and its proposed future contributions to both ELIXIR and the broader community of systems biologists in Europe and worldwide. The Community believes that the infrastructure aspects of systems biology - databases, (modelling) tools and standards development, as well as training and access to cloud infrastructure - are not only appropriate components of the ELIXIR infrastructure, but will prove key components of ELIXIR’s future support of advanced biological applications and personalised medicine. By way of a series of meetings, the Community identified seven key areas for its future activities, reflecting both future needs and previous and current activities within ELIXIR Platforms and Communities. These are: overcoming barriers to the wider uptake of systems biology; linking new and existing data to systems biology models; interoperability of systems biology resources; further development and embedding of systems medicine; provisioning of modelling as a service; building and coordinating capacity building and training resources; and supporting industrial embedding of systems biology. A set of objectives for the Community has been identified under four main headline areas: Standardisation and Interoperability, Technology, Capacity Building and Training, and Industrial Embedding. These are grouped into short-term (3-year), mid-term (6-year) and long-term (10-year) objectives.
- Open Access
- 27 February 2024
- Published by Frontiers Media SA in Frontiers in Systems Biology
- Vol. 4, 1363884
BioModels’ Model of the Year 2023
Mathematical modeling is a pivotal tool for deciphering the complexities of biological systems and their control mechanisms, providing substantial benefits for industrial applications and answering relevant biological questions. BioModels’ Model of the Year 2023 competition was established to recognize and highlight exciting modeling-based research in the life sciences, particularly by non-independent early-career researchers. It further aims to endorse reproducibility and FAIR principles of model sharing among these researchers. We here delineate the competition’s criteria for participation and selection, introduce the award recipients, and provide an overview of their contributions. Their models provide crucial insights into cell division regulation, protein stability, and cell fate determination, illustrating the role of mathematical modeling in advancing biological research.
- 27 February 2024
- Published by Frontiers Media SA in Frontiers in Systems Biology
- Vol. 4, 1363884
Open AccessBioModels’ Model of the Year 2023
Mathematical modeling is a pivotal tool for deciphering the complexities of biological systems and their control mechanisms, providing substantial benefits for industrial applications and answering relevant biological questions. BioModels’ Model of the Year 2023 competition was established to recognize and highlight exciting modeling-based research in the life sciences, particularly by non-independent early-career researchers. It further aims to endorse reproducibility and FAIR principles of model sharing among these researchers. We here delineate the competition’s criteria for participation and selection, introduce the award recipients, and provide an overview of their contributions. Their models provide crucial insights into cell division regulation, protein stability, and cell fate determination, illustrating the role of mathematical modeling in advancing biological research.